Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 symbols : INCY save search
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -0.89%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -0.06%
H: 0.28%
C: 0.18%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
ema car-t platform
Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
therapy
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-11-04 (Crawled : 09:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
new drug treatment application therapy drug
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.